Tulasne D, Foveau B
CNRS UMR 8161, Institut de Biologie de Lille-Institut Pasteur de Lille-Université de Lille 1-Université de Lille 2, IFR142, B.P.447, 59021 Lille Cedex, France.
Cell Death Differ. 2008 Mar;15(3):427-34. doi: 10.1038/sj.cdd.4402229. Epub 2007 Oct 5.
The MET tyrosine kinase receptor is a high-affinity receptor for hepatocyte growth factor/scatter factor (HGF/SF). HGF/SF-MET system is necessary for embryonic development, and aberrant MET signalling favours tumorigenesis and metastasis. MET is a prototype of tyrosine kinase receptor, which is able to counteract apoptosis through the initiation of a survival signal involving notably the PI3K-Akt pathway. Paradoxically, the MET receptor is also able to promote apoptosis when activated by HGF/SF or independently of ligand stimulation. The molecular mechanisms underlying this uncommon response have been recently investigated and revealed dual antiapoptotic or proapoptotic property of MET according to the cell type or stress conditions. Although the involvement of MET in the regulation of integrated biological responses mostly took into account its efficient antiapoptotic function, its proapoptotic responses could also be important for regulation of the survival/apoptosis balance and play a role during the development or tumour progression.
MET酪氨酸激酶受体是肝细胞生长因子/分散因子(HGF/SF)的高亲和力受体。HGF/SF-MET系统对胚胎发育至关重要,而MET信号异常有利于肿瘤发生和转移。MET是酪氨酸激酶受体的原型,它能够通过启动一个主要涉及PI3K-Akt途径的生存信号来对抗细胞凋亡。矛盾的是,MET受体在被HGF/SF激活或独立于配体刺激时也能够促进细胞凋亡。最近对这种不寻常反应背后的分子机制进行了研究,结果表明,根据细胞类型或应激条件,MET具有双重抗凋亡或促凋亡特性。尽管MET参与整合生物学反应的调节主要考虑了其有效的抗凋亡功能,但其促凋亡反应对于生存/凋亡平衡的调节也可能很重要,并在发育或肿瘤进展过程中发挥作用。